Last reviewed · How we verify
NCT03426774
Simulated Passive Jogging & Jumping Devices & NO
NA trial testing Gentle Jogger in Physical Activity in 22 participants. Completed in 23 January 2020.
23 January 2020
Quick facts
| Lead sponsor | Sackner Wellness Products LLC |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | other |
| Enrollment | 22 |
| Start date | 1 March 2017 |
| Primary completion | 23 January 2020 |
| Estimated completion | 23 January 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Gentle Jogger
- Gentle Jumper
Conditions studied
- Physical Activity — all drugs for Physical Activity →
- Blood Pressure — all drugs for Blood Pressure →
Sponsor
Sackner Wellness Products LLC
Who can join
25 and older, any sex, with Physical Activity or Blood Pressure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Movement is important for overall health. Lack of movement has been shown to be associated with numerous diseases. This study will assess the validity and usefulness of two innovative low risk, non-invasive wellness devices, the Gentle Jogger® and the Gentle Jumper that passively simulate the physical activities of jogging and jumping, respectively. The study will evaluate whether or not each of the devices in different body postures (seated, lying down, slight recumbent and slight head down) produces changes in blood pressure, and indices of dilatation of blood vessels, in a younger (25-59yr) and older (\> 60 yrs.) subject population. Volunteers will be paid for their participation in the study. A substudy of this larger study ( Effects of Gentle Jogger on blood pressure), will determine the effects of 30 min of gentle jogger in seated and supine posture compared to Sham
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Changes of blood pressure following initiation of physical inactivity and after external addition of pulses to circulation.
Sackner MA, Patel S, Adams JA. · · 2019 · cited 15× · PMID 30350153 · DOI 10.1007/s00421-018-4016-7 -
The Effects of Passive Simulated Jogging on Short-Term Heart Rate Variability in a Heterogeneous Group of Human Subjects.
Adams JA, Patel S, Lopez JR, Sackner MA. · · 2018 · cited 12× · PMID 30402499 · DOI 10.1155/2018/4340925 -
The effects of a motorized passive simulated jogging device on descent of the arterial pulse waveform dicrotic notch: A single arm placebo-controlled cross-over trial.
Adams JA, Lopez JR, Nadkarni V, Zolkipli-Cunningham Z, et al · · 2022 · cited 3× · PMID 35924333 · DOI 10.14814/phy2.15418
Verify or expand the search:
- PubMed search for NCT03426774
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Gentle Jogger
Trials testing the same drug.
- NCT03550105 — Effects of Simulated Passive Jogging Device on Glucose Homeostasis, Muscle Strength and Endurance · NA · completed
Other recruiting trials for Physical Activity
Currently open trials in the same condition.
- NCT07466797 — The eHealth Integrated Maternal Physical Activity Programme in Prenatal Care Trial (E-IMPACT) · NA · recruiting
- NCT07466914 — Constipation in Children With Cerebral Palsy · active not recruiting
- NCT07290309 — Survivors Uniting for Remote Guided Exercise · NA · recruiting
- NCT07415460 — Evaluating the Impact of SKY Breath Meditation on Stress, Well-being, and Connection in College Students · NA · recruiting
- NCT07585409 — Physical Activity in Persons With Parkinson's Disease · recruiting
Other Sackner Wellness Products LLC trials
Trials by the same sponsor.
- NCT03550105 — Effects of Simulated Passive Jogging Device on Glucose Homeostasis, Muscle Strength and Endurance · NA · completed
- NCT03602365 — Gentle Jogger and Oxygen Consumption · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03426774 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sackner Wellness Products LLC
- Last refreshed: 27 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03426774.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing